NewAmsterdam Pharma Company N.V.
NAMS
$36.40
-$0.07-0.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 71.62% | 68.03% | 145.03% | 0.97% | 2.88% |
| Total Receivables | 265.33% | -60.97% | 1,032.64% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.40% | -21.73% | 77.53% | -- | 46.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 72.86% | 67.54% | 148.97% | -- | 4.80% |
|
|
|||||
| Total Current Assets | 72.86% | 67.54% | 148.97% | -- | 4.80% |
| Net Property, Plant & Equipment | -21.32% | 336.69% | 566.34% | -- | 544.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -13.28% | 3.29% | 214.12% | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -99.99% |
| Total Assets | 82.48% | 67.55% | 149.10% | -- | -13.15% |
|
|
|||||
| Total Accounts Payable | 11.75% | -28.69% | -71.97% | -- | -76.83% |
| Total Accrued Expenses | -7.20% | -19.55% | 19.39% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.85% | 486.05% | 310.00% | -- | 234.76% |
| Total Finance Division Other Current Liabilities | -29.29% | -35.51% | 310.49% | -- | 55.69% |
| Total Other Current Liabilities | -29.29% | -35.51% | 310.49% | -- | 55.69% |
| Total Current Liabilities | -19.41% | -31.50% | 114.28% | -- | 8.26% |
|
|
|||||
| Total Current Liabilities | -19.41% | -31.50% | 114.28% | -- | 8.26% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -68.60% | -- | -- | -- | 1,206.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 19.06% |
| Total Liabilities | -38.20% | -46.45% | 82.47% | -- | 11.14% |
|
|
|||||
| Common Stock & APIC | 66.87% | 67.58% | 118.26% | -- | 25.31% |
| Retained Earnings | -36.85% | -45.61% | -76.22% | -- | -111.85% |
| Treasury Stock & Other | -2.15% | 0.27% | 1.02% | -- | -49.20% |
| Total Common Equity | 100.93% | 88.77% | 162.66% | -17.82% | -15.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 100.93% | 88.77% | 162.66% | -17.82% | -15.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 100.93% | 88.77% | 162.66% | -17.82% | -15.95% |
|
|
|||||